Supraventricular tachycardia (SVT) is rarely life-threatening on its own. In patients without underlying structural heart disease, the case fatality rate is around 1%. Most episodes feel alarming but resolve without lasting damage. That said, certain subtypes carry higher risk, and frequent or prolonged episodes can weaken the heart over time if left untreated.
Why Most SVT Episodes Aren’t Dangerous
During an SVT episode, the heart races at 150 to 250 beats per minute due to a short circuit in its electrical system. The rapid rate can cause palpitations, dizziness, chest tightness, and a sense of panic. These symptoms feel intense, but in a structurally normal heart, the episodes typically end on their own or respond to simple techniques like bearing down (a Valsalva maneuver). The heart muscle isn’t being damaged during a brief episode.
The main reason SVT stays low-risk for most people is that it originates above the ventricles, the heart’s main pumping chambers. The ventricles still contract in an organized way, just faster than normal. This is fundamentally different from ventricular arrhythmias, where the pumping chambers themselves malfunction and blood flow can drop dangerously.
When SVT Becomes a Real Concern
Risk rises in a few specific situations. The most notable is Wolff-Parkinson-White (WPW) syndrome, a condition where an extra electrical pathway connects the upper and lower chambers of the heart. In WPW, SVT episodes can occasionally trigger a dangerously fast, chaotic rhythm. The estimated risk of sudden cardiac death in symptomatic WPW patients is about 0.25% per year, or 3% to 4% over a lifetime. That’s low, but not negligible, and it’s why WPW is treated more aggressively than other forms of SVT.
Risk factors that increase the danger in WPW include having multiple extra pathways, being male, a history of fainting during episodes, and younger age. In one large study, about 1.1% of WPW patients experienced a cardiovascular collapse requiring resuscitation or defibrillation. Catheter ablation to destroy the extra pathway is typically recommended for these patients rather than watchful waiting.
SVT also poses more risk when structural heart disease is already present. In pediatric patients with SVT and underlying heart defects, the fatality rate jumps to around 6%, six times higher than the 1% seen in children with normal hearts. Adults with pre-existing heart failure or weakened heart muscle face similar increases in risk during sustained fast heart rates.
How Frequent SVT Can Weaken the Heart
Even without an immediately dangerous episode, SVT that goes untreated for months or years can gradually damage the heart. When the heart beats too fast too often, it doesn’t have time to fill properly between beats, and the muscle itself becomes strained. This is called tachycardia-induced cardiomyopathy, a form of heart failure caused purely by the fast rate. In studies of patients with sustained rapid heart rhythms, 25% to 75% of those who developed weakened heart function had some degree of this condition.
The encouraging part is that tachycardia-induced cardiomyopathy is largely reversible. Once the heart rate is controlled, either through medication or ablation, the heart muscle typically recovers much of its strength. But this recovery depends on catching the problem before permanent structural changes set in, which is why people with frequent SVT episodes shouldn’t simply accept them as a nuisance.
The Impact on Daily Life
Even when SVT isn’t medically dangerous, it takes a real toll. Unpredictable episodes of racing heartbeat, dizziness, and fatigue lead many people to restrict their physical activity, avoid exercise, and develop anxiety about when the next episode will strike. Research consistently shows that SVT significantly reduces quality of life across physical, social, and psychological dimensions. People report limiting travel, social events, and work because of fear of an episode.
This is worth taking seriously because effective treatment exists. In one study, patients’ quality of life scores nearly doubled within a month after catheter ablation, improving from an average of 33.7 to 62.5 on a standardized scale. Both physical and mental health measures improved significantly.
How SVT Is Treated
For occasional, brief episodes, you can often stop an SVT episode at home using vagal maneuvers. These are simple physical techniques that stimulate the vagus nerve and slow the heart’s electrical signals. The standard approach is to bear down hard as if straining during a bowel movement. A modified version, where you blow forcefully into a syringe while sitting up and then immediately lie flat with your legs raised, converts SVT back to a normal rhythm about 43% of the time, compared to roughly 11% for the standard technique alone.
For people with frequent or bothersome episodes, catheter ablation is the definitive treatment. A thin wire is threaded through a blood vessel to the heart, where it delivers energy to destroy the tiny area of tissue causing the short circuit. The procedure succeeds in eliminating the target rhythm about 96% of the time. Recurrence after a successful ablation is around 7%, with most recurrences happening within the first six months. For the small number whose SVT returns, a repeat procedure is usually effective.
Daily medications that slow the heart rate or suppress the abnormal electrical signals are another option, particularly for people who prefer not to have a procedure or who have infrequent episodes. These work well for many patients but don’t cure the underlying problem, so symptoms return if the medication is stopped.
Symptoms That Need Emergency Attention
Most SVT episodes, while uncomfortable, can be managed at home with vagal maneuvers and patience. But a racing heart that lasts more than a few minutes and comes with chest pain, significant dizziness, shortness of breath, or weakness warrants a call to emergency services. These symptoms can indicate that the heart isn’t pumping enough blood to meet the body’s needs, or that something more serious than typical SVT is happening. Fainting during an episode is particularly important to report to your cardiologist, as it may point toward a higher-risk subtype like WPW.